+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Extrapyramidal effects of acute organophosphate poisoning



Extrapyramidal effects of acute organophosphate poisoning



Clinical Toxicology 54(3): 259-265



There is limited information on extrapyramidal symptoms in acute organophosphate (OP) poisoning. We describe the course and outcome of severely poisoned patients who develop extrapyramidal manifestations. In this prospective observational study, spanning 8 months (Apr-Nov 2013) adult patients (>18 years) admitted with OP poisoning were enrolled. Patients on anti-psychotic therapy, those refusing consent or presenting with co-ingestions were excluded. Treatment included atropine and supportive care (e.g. ventilation and inotropes as indicated); oximes were not administered. The presence of rigidity, tremors, dystonia and chorea were assessed daily till discharge using modifications of the Unified Parkinson's Disease rating scale and the Tremor rating scale. The presence of extrapyramidal manifestations was correlated with length of ventilation and hospital stay and mortality. Of the 77 patients admitted with OP poisoning, 32 were enrolled; 17 (53.1%) developed extrapyramidal manifestations which included rigidity (94.1%), tremors (58.8%) and dystonia (58.8%). None developed chorea. The median (inter-quartile range) time of symptom onset was 8 (5-11) days; extrapyramidal features resolved in 11 (6-17) days. The median duration of intensive care stay in patients not developing extrapyramidal symptoms was 6 (2-8) days, indicating that most of these patients had recovered even before symptom onset in patients who developed extrapyramidal manifestations. Overall, 27/32 (84%) were ventilated. Hospital mortality was 6.25% (2/32). When compared with patients not developing extrapyramidal signs, those with extrapyramidal manifestations had significantly prolonged ventilation (5 versus 16 median days; p = 0.001) and hospitalization (8 versus 21 days; p < 0.001), reduced ventilator-free days (23 versus 12 days; p = 0.023) and increased infections (p = 0.03). The need for ventilation and mortality were not significantly different (p > 0.6). Extrapyramidal symptoms were not observed in non-OP poisoned patients with prolonged ICU stay. In this small series of acute OP poisoning, extrapyramidal manifestations were common after 1 week of intensive care but self-limiting. They are significantly associated with longer duration of ventilation and hospital stay.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057850628

Download citation: RISBibTeXText

PMID: 26735571

DOI: 10.3109/15563650.2015.1126841


Related references

Extrapyramidal parkinsonism complicating acute organophosphate insecticide poisoning. Pediatric Neurology 33(5): 378-382, 2005

Extrapyramidal syndrome as a delayed and reversible complication of acute dichlorvos organophosphate poisoning. Veterinary and Human Toxicology 46(4): 187-189, 2004

Bioscavenger therapy for organophosphate poisoning - an open-labeled pilot randomized trial comparing fresh frozen plasma or albumin with saline in acute organophosphate poisoning in humans. Clinical Toxicology 48(8): 813-819, 2010

Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes. Journal of Physiology, Paris 92(5-6): 375-378, 1998

Effects of acute organophosphate poisoning on pituitary target gland hormones at admission, discharge and three months after poisoning: A hospital based pilot study. Indian Journal of Endocrinology and Metabolism 19(1): 116-123, 2015

Ultrastructural effects of acute organophosphate poisoning on rat kidney. Renal Failure 27(5): 623-627, 2005

Effects of acute organophosphate poisoning on thyroid hormones in rats. American Journal of Therapeutics 12(3): 238-242, 2005

Central nervous system effects of acute organophosphate poisoning in a two-year follow-up. Scandinavian Journal of Work, Environment & Health 30(5): 362-370, 2004

Cardiac damage in acute organophosphate poisoning in rats: effects of atropine and pralidoxime. American Journal of Emergency Medicine 27(2): 169-175, 2009

Respiratory failure induced by acute organophosphate poisoning in rats: effects of vagotomy. Neurotoxicology 30(2): 298-304, 2010

Effects of Acute Organophosphate Poisoning on Glycemic Profile in Weanling Rats An experimental study. Revista de Chimie 69(12): 3469-3472, 2018

Poisoning severity score, Glasgow coma scale, corrected QT interval in acute organophosphate poisoning. Human and Experimental Toxicology 29(5): 419-425, 2010

Management of acute endosulfan poisoning in an organophosphate poisoning clinic. Clinical Toxicology 45(5): 563-564, 2007

Neurophysiological monitoring of pharmacological manipulation in acute organophosphate (OP) poisoning. The effects of pralidoxime, magnesium sulphate and pancuronium. Electroencephalography and Clinical Neurophysiology 107(2): 140-148, 1998

Cardiac effects of magnesium sulfate pretreatment on acute dichlorvos-induced organophosphate poisoning: an experimental study in rats. Biological Trace Element Research 133(2): 227-235, 2010